| ASSET | WEEK | % RETURN |
|---|---|---|
Beyond Meat (BYND) | 10/20/2025 - 10/26/2025 | 114.22% |
Alto Neuroscience (ANRO) | 10/20/2025 - 10/26/2025 | 62.96% |
GCM Grosvenor (GCMGW) | 10/20/2025 - 10/26/2025 | 61.12% |
Neumora Therapeutics (NMRA) | 10/20/2025 - 10/26/2025 | 52.02% |
Inhibrx Biosciences (INBX) | 10/20/2025 - 10/26/2025 | 51.88% |
Bally's (BALY) | 10/20/2025 - 10/26/2025 | 47.91% |
Core Laboratories (CLB) | 10/20/2025 - 10/26/2025 | 47.89% |
Ventyx Biosciences (VTYX) | 10/20/2025 - 10/26/2025 | 45.43% |
MidWestOne Financial (MOFG) | 10/20/2025 - 10/26/2025 | 41.92% |
Newegg Commerce (NEGG) | 10/20/2025 - 10/26/2025 | 41.3% |
Nuvation Bio (NUVB) | 10/20/2025 - 10/26/2025 | 39.77% |
Clover Health Investments (CLOV) | 10/20/2025 - 10/26/2025 | 38.41% |
Winnebago Industries (WGO) | 10/20/2025 - 10/26/2025 | 31.99% |
Community Health Systems (CYH) | 10/20/2025 - 10/26/2025 | 31.83% |
Invivyd (IVVD) | 10/20/2025 - 10/26/2025 | 29.65% |
Mayville Engineering (MEC) | 10/20/2025 - 10/26/2025 | 29.26% |
Asset Entities Inc Class B Common Stock (ASST) | 10/20/2025 - 10/26/2025 | 27.89% |
Inventiva (IVA) | 10/20/2025 - 10/26/2025 | 27.84% |
MBX Biosciences, Inc Common Stock (MBX) | 10/20/2025 - 10/26/2025 | 27.63% |
Nutex Health (NUTX) | 10/20/2025 - 10/26/2025 | 26.79% |
Geospace Technologies (GEOS) | 10/20/2025 - 10/26/2025 | 25.1% |
iHeartMedia Inc Class A (IHRT) | 10/20/2025 - 10/26/2025 | 24.63% |
China Yuchai International (CYD) | 10/20/2025 - 10/26/2025 | 23.87% |
Claritev (CTEV) | 10/20/2025 - 10/26/2025 | 23.56% |
Better Home & Finance (BETR) | 10/20/2025 - 10/26/2025 | 23.02% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
